Tenet Healthcare (THC) Is Up 19.8% After Q4 Beat And Higher 2026 Profit Guidance - What's Changed

Simply Wall St.00:20

In February 2026, Tenet Healthcare reported fourth-quarter 2025 results with revenue rising to US$5,527 million and net income increasing to US$371 million, while issuing 2026 guidance that points to ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2612481567?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821","is_english":true,"pubTime":"2026-02-17 00:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2612481567","market":"us","top_or_hot":-1,"title":"Tenet Healthcare (THC) Is Up 19.8% After Q4 Beat And Higher 2026 Profit Guidance - What's Changed","media":"Simply Wall St.","content":"<div>\n<p>In February 2026, Tenet Healthcare reported fourth-quarter 2025 results with revenue rising to US$5,527 million and net income increasing to US$371 million, while issuing 2026 guidance that points to ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-thc/tenet-healthcare/news/tenet-healthcare-thc-is-up-198-after-q4-beat-and-higher-2026\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tenet Healthcare (THC) Is Up 19.8% After Q4 Beat And Higher 2026 Profit Guidance - What's Changed</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTenet Healthcare (THC) Is Up 19.8% After Q4 Beat And Higher 2026 Profit Guidance - What's Changed\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-17 00:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-thc/tenet-healthcare/news/tenet-healthcare-thc-is-up-198-after-q4-beat-and-higher-2026><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In February 2026, Tenet Healthcare reported fourth-quarter 2025 results with revenue rising to US$5,527 million and net income increasing to US$371 million, while issuing 2026 guidance that points to ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-thc/tenet-healthcare/news/tenet-healthcare-thc-is-up-198-after-q4-beat-and-higher-2026\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-thc/tenet-healthcare/news/tenet-healthcare-thc-is-up-198-after-q4-beat-and-higher-2026","article_id":"2612481567","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-thc/tenet-healthcare/news/tenet-healthcare-thc-is-up-198-after-q4-beat-and-higher-2026","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2612481567","pubTimestamp":1771258803,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"In February 2026, Tenet Healthcare reported fourth-quarter 2025 results with revenue rising to US$5,527 million and net income increasing to US$371 million, while issuing 2026 guidance that points to higher net income and earnings per share versus 2025.\nBeneath the headline numbers, management highlighted continued expansion of its higher-margin ambulatory surgery business and a completed Conifer Health Solutions transaction as key earnings drivers.\nAgainst this backdrop, we’ll examine how...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","THC.AU":"Hydroponics Company","BK4585":"ETF&股票定投概念","LU0130103400.USD":"Natixis Harris Associates Global Equity RA USD","LU0963586101.USD":"ALLIANZ GLOBAL SMALL CAP EQUITY \"AT\" ACC","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","LABU":"三倍做多标普生物-Direxion","XBI":"SPDR S&P Biotech ETF","XLV":"健康照护类股ETF-SPDR","LU1201861165.SGD":"Natixis Harris Associates Global Equity PA SGD","BK4581":"高盛持仓","THC":"泰尼特","BK4185":"保健护理机构","LU0648000940.SGD":"Natixis Harris Associates Global Equity RA SGD"},"translate_title":"Tenet Healthcare(THC)在第四季度超出预期并提高2026年利润指引后上涨19.8%-发生了什么变化","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XLV":1.5,"LABU":0.6,"THC.AU":1.5,"XBI":0.6,"THC":1.5},"content_text":"In February 2026, Tenet Healthcare reported fourth-quarter 2025 results with revenue rising to US$5,527 million and net income increasing to US$371 million, while issuing 2026 guidance that points to higher net income and earnings per share versus 2025. Beneath the headline numbers, management highlighted continued expansion of its higher-margin ambulatory surgery business and a completed Conifer Health Solutions transaction as key earnings drivers. Against this backdrop, we’ll examine how Tenet’s emphasis on growing its ambulatory surgery segment could shape the company’s broader investment narrative. Capitalize on the AI infrastructure supercycle with our selection of the 34 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.AdvertisementWhat Is Tenet Healthcare's Investment Narrative?To own Tenet Healthcare today, you have to buy into a story of mix shift: a hospital operator leaning harder into higher‑margin ambulatory surgery while simplifying the rest of the portfolio. The latest quarter, with revenue up to US$5,527 million and net income at US$371 million, reinforced that message and was followed by 2026 guidance that points to higher net income and earnings per share versus 2025. The completed Conifer Health Solutions transaction and a sizable buyback program, which has retired just over 10% of shares, both feed into a cleaner, more focused equity story and helped fuel the recent double‑digit share price move. In the near term, execution in ambulatory growth and integration of recent deals look like the key catalysts, while high leverage, volatile profit margins and insider selling sit near the top of the risk list. However, investors should also be aware of how Tenet’s high debt load could constrain flexibility.\n\nTenet Healthcare's shares have been on the rise but are still potentially undervalued. Find out how large the opportunity might be.Exploring Other PerspectivesTHC 1-Year Stock Price Chart Four fair value estimates from the Simply Wall St Community span roughly US$211 million to above US$648 million, underscoring how far apart individual views can be. When you set that against Tenet’s debt burden and the market’s focus on ambulatory surgery growth, it highlights why many market participants are rethinking what could realistically drive the next phase of performance.Explore 4 other fair value estimates on Tenet Healthcare - why the stock might be worth over 2x more than the current price!Build Your Own Tenet Healthcare NarrativeDisagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.A great starting point for your Tenet Healthcare research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.Our free Tenet Healthcare research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Tenet Healthcare's overall financial health at a glance.Looking For Alternative Opportunities?Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:The future of work is here. Discover the 32 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.Outshine the giants: these 27 early-stage AI stocks could fund your retirement.Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 30 best rare earth metal stocks of the very few that mine this essential strategic resource.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Tenet Healthcare might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2612481567","isCrawlerRequest":true}